Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that it has completed the rolling submission of its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA), ...

A live webcast and replay of the fireside chat will be available on the Company’s investors relations website at https://investors.treace.com/.

MENLO PARK, Calif., Dec. 30, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be ...

Terah Krigsvold to replace Andrea Goren as CFO, who is named chief business officer and CEO of INVO Centers LLC to focus on growth efforts ...

Breathalyser SSP is a leading distributor of alcohol and drug testing devices for employers and personal use for the Australian market. The company operates regional offices in Perth, Melbourne, and ...